Clinical trial
Tolerance and Efficacy of Rituximab in Sjogren's Disease
NCT00740948 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerance and Efficacy of Rituximab in Sjogren's Disease
- Lead sponsor
- University Hospital, Brest
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- January 31, 2013
- Enrollment
- 122 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
sjogren's disease